NCT00376636View on ClinicalTrials.gov

Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

May 31, 2007

Conditions

Hypertension

Interventions

DRUG

SPP635 (drug)

Trial Locations (1)

68167

IKP Bobenheim GmbH, Mannheim

All Listed Sponsors

lead

Speedel Pharma Ltd.

INDUSTRY

NCT00376636 - Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension | Biotech Hunter | Biotech Hunter